Variants of TREM2, whose CNS expression is restricted to microglia (Schmid et al., 2002), increase the risk of AD (Guerreiro et al., 2013), consolidating the neuroinflammation-AD link. This evidence concerns the gene TREM2 and Alzheimer disease.